PDIK1L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.926400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.649200E-01
Normal-vs-Stage2
6.628200E-02
Normal-vs-Stage3
1.836710E-03
Normal-vs-Stage4
4.233800E-01
Stage1-vs-Stage2
3.819000E-01
Stage1-vs-Stage3
7.164400E-02
Stage1-vs-Stage4
9.596200E-01
Stage2-vs-Stage3
1.796770E-01
Stage2-vs-Stage4
4.330000E-01
Stage3-vs-Stage4
1.511190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.870200E-02
Normal-vs-AfricanAmerican
7.208600E-01
Normal-vs-Asian
8.334500E-02
Caucasian-vs-AfricanAmerican
6.937600E-02
Caucasian-vs-Asian
6.478800E-01
AfricanAmerican-vs-Asian
1.620620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.042300E-02
Normal-vs-Female
1.084360E-01
Male-vs-Female
4.397000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.515620E-02
Normal-vs-Age(41-60Yrs)
1.737040E-01
Normal-vs-Age(61-80Yrs)
5.432200E-02
Normal-vs-Age(81-100Yrs)
1.427960E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.385000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.353200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.219200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.236300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.799700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.607400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.912500E-02
Normal-vs-Daily Drinker
1.200780E-01
Normal-vs-Weekly Drinker
3.237000E-03
Normal-vs-Occasional Drinker
3.211600E-01
Normal-vs-Social Drinker
1.488630E-01
Non Drinker-vs-Daily Drinker
7.709600E-01
Non Drinker-vs-Weekly Drinker
2.627400E-01
Non Drinker-vs-Occasional Drinker
6.911600E-02
Non Drinker-vs-Social Drinker
4.180000E-01
Daily Drinker-vs-Weekly Drinker
2.669000E-01
Daily Drinker-vs-Occasional Drinker
2.125000E-01
Daily Drinker-vs-Social Drinker
6.698400E-01
Weekly Drinker-vs-Occasional Drinker
1.699720E-02
Weekly Drinker-vs-Social Drinker
1.103950E-01
Occasional Drinker-vs-Social Drinker
4.373000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.614390E-01
Normal-vs-Grade 2
1.107410E-01
Normal-vs-Grade 3
9.964100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.058000E-01
Grade 1-vs-Grade 3
8.621800E-01
Grade 1-vs-Grade 4
1.614390E-01
Grade 2-vs-Grade 3
8.230600E-01
Grade 2-vs-Grade 4
1.107410E-01
Grade 3-vs-Grade 4
9.964100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.169950E-02
Normal-vs-NonDiabetic
6.833900E-02
Diabetic-vs-NonDiabetic
1.162750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.177900E-02
Normal-vs-NoPancreatitis
5.313600E-02
Pancreatitis-vs-NoPancreatitis
3.855400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.092100E-02
Normal-vs-N1
7.203800E-02
N0-vs-N1
9.636800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.676800E-01
Normal-vs-TP53-NonMutant
3.916200E-01
TP53-Mutant-vs-TP53-NonMutant
4.345800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
